Lilly to invest another $5.3B in Lebanon to meet demand for Mounjaro, Zepbound
Faced with overwhelming demand for its diabetes treatment Mounjaro and weight-loss treatment Zepbound, Indianapolis-based drugmaker Eli Lilly and Co. said Friday it plans to invest another $5.3 billion in its brand-new Boone County manufacturing complex.... Read More
